SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-162548
Filing Date
2018-05-14
Accepted
2018-05-14 16:10:06
Documents
3
Period of Report
2018-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d586046d8k.htm 8-K 15217
2 EX-99.1 d586046dex991.htm EX-99.1 43974
3 GRAPHIC g586046g0511062154295.jpg GRAPHIC 3532
  Complete submission text file 0001193125-18-162548.txt   65322
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 18830669
SIC: 2834 Pharmaceutical Preparations